Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by hcdtradingon Dec 19, 2017 9:35pm
117 Views
Post# 27192338

RE:RE:RE:Shareholder Syndrome

RE:RE:RE:Shareholder SyndromeDoes Wex and stockarch work for Sirona?  there they go again spinning a not great news release into a fine one.  Always blue skys no grey.  It reads bad no matter how hard you look and try to spin it. They were probably told to go do clinicals and then maybe if those are good we will think about it doing a deal with you. and it's not like SBM has any bargaining power here.  Sirona is the biatch here and the large pharm corp has all the power.   I said on a previous post I would bet my life no deal in 2017 so thank all fake gods on that one.    Not to pile on here but the chart is reading for new lows.  Very bearish after looking at today's chart.  I own stock and don't like saying negatives but I am a realist and will not tell myself everything is great when it is clearly not. 
Bullboard Posts